Desmosine (D) and isodesmosine (I), the intramolecular crosslinking amino acids that occur in chains of elastin, have now been found in free form in human urine. Until now, these amino acids (Mr ‫؍‬ 526) were found to occur in urine only as higher molecular weight (Mr ‫؍‬ 1,000 -1,500) peptides. Thus, the previously used analytical methods required, as the first step, acid hydrolysis of the urine at elevated temperature to liberate D and I from their peptides. The analytical method described here uses HPLC followed by electrospray ionization MS for the detection and quantitation of free D and I in unhydrolyzed urine. Identities of both D and I were established by their retention times on LC and by their mass ion at 526 atomic mass units, characteristic of each compound. The sensitivity of the method is 0.10 ng. The average values of free D and I in the urine of seven healthy subjects were 1.42 ؎ 1.16 and 1.39 ؎ 1.04 g͞g of creatinine, respectively. After acid hydrolysis of the urine, the amounts of D and I were 8.67 ؎ 3.75 and 6.28 ؎ 2.87 g͞g of creatinine, respectively. The method was also successfully used to measure peptide-bound D and I levels in the sputum of patients with chronic obstructive pulmonary disease. T wo pyridinium amino acids, desmosine (D) and isodesmosine (I), are positional isomers that serve as crosslinking molecules binding the polymeric chains of amino acids into the 3D network of elastin (1-3). The degradation of elastin-containing tissues that occurs in several widely prevalent diseases, such as pulmonary emphysema, chronic obstructive pulmonary disease (COPD), cystic fibrosis, atherosclerosis, aortic aneurysm, etc., has been associated with the excretion in the urine of peptic derivatives of these two pyridinium compounds (4-13). Previously identified (14) urinary metabolites are a group of high molecular weight polypeptic derivatives of D and I ranging in M r from 1,000 to 1,500. In this paper, we report that D and I are also excreted in urine in free form. Moreover, after hydrolysis, D and I have been found in sputum obtained from patients with COPD.
T wo pyridinium amino acids, desmosine (D) and isodesmosine (I), are positional isomers that serve as crosslinking molecules binding the polymeric chains of amino acids into the 3D network of elastin (1) (2) (3) . The degradation of elastin-containing tissues that occurs in several widely prevalent diseases, such as pulmonary emphysema, chronic obstructive pulmonary disease (COPD), cystic fibrosis, atherosclerosis, aortic aneurysm, etc., has been associated with the excretion in the urine of peptic derivatives of these two pyridinium compounds (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Previously identified (14) urinary metabolites are a group of high molecular weight polypeptic derivatives of D and I ranging in M r from 1,000 to 1,500. In this paper, we report that D and I are also excreted in urine in free form. Moreover, after hydrolysis, D and I have been found in sputum obtained from patients with COPD.
Previously used techniques for the analysis of urinary D and I have used RIA (15, 16) , HPLC (17) (18) (19) , and capillary zone electrophoresis (20, 21) . In each case, acid hydrolysis (treatment of the urine with HCl at elevated temperature for 24 h) was used as the first step to liberate D and I from their peptidic conjugates. The analytical method described here is sufficiently sensitive and specific so that it is possible to analyze for free D and I even though they are less abundant in urine than their peptidic forms. The method involves HPLC followed by electrospray ionization MS (ESIMS). Besides, avoiding the drastic HCl hydrolysis (which severely complicates the subsequent purification process), this method makes possible the identification of D and I with high specificity and sensitivity, such that the analysis of only 1-3 ml of urine is possible. Moreover, other fluids of concern (sputum, lung lavage, etc.) where only small samples are available may also be analyzed by this method.
Tens of millions of people in this country alone suffer from various forms of lung disease, and consequently the method described here may find clinical use to determine elastin tissue destruction, to evaluate pathogenesis and severity of lung disease, and to estimate the efficacy of potential therapies. Creatinine and Protein Measurement. Urine creatinine was measured by the commercially available 555A creatinine kit (Sigma). Total protein in sputum samples was measured by the commercially available microprotein assay kit (Sigma), which is based on protein-dye (Coomassie blue) binding (22) .
Materials and Methods
Sample Preparation for LC͞MS Analysis. Urine and sputum samples were obtained from volunteers with informed consent at the James P. Mara Center for Lung Disease, St. Luke's͞Roosevelt Hospital Center, New York.
Urine Samples. Twenty-four-hour urine samples were collected in 0.2% boric acid and stored at Ϫ20°C before analysis. Sputum from patients with previously diagnosed COPD was produced spontaneously and collected over a 3-h period in plastic containers before analysis.
For determination of free D and I, 1-3 ml of urine was mixed with an equal volume of 0.1 M HCl and applied to 3 ml of MCX cation-exchange column (Waters), which had been prewashed with 3 ml of methanol and 3 ml of H 2 O. The column was then washed with 3 ml of H 2 O͞3 ml of methanol followed by 3 ml 0.1 M HCl. The D and I adsorbed on the column were finally eluted with 3 ml of 2 M HCl. This eluate was evaporated to dryness under vacuum at 45°C. The dry residue was dissolved in 0.1 ml of HPLC mobile phase used in the LC͞ESIMS analysis.
For the determination of total (both free and peptide-bound) D and I, the urine sample was added to an equal volume of conc. HCl (12 M) in a glass vial; the air in the vial was displaced by a stream of nitrogen, and then the capped vial was heated at 110°C for 24 h. The acid hydrolyzed mixture was filtered, the filtrate was evaporated to dryness at 45°C under vacuum, and the residue was chromatographed on the cation-exchange column as described above. The appropriate elute was analyzed by LC͞ESIMS.
Sputum Samples. Sputum samples of COPD were collected at the clinic. Sputum from subjects with no history or evidence of lung disease was produced by a sputum induction procedure by using inhalation of 3% sodium chloride aerosol over 20 min. One-half to 1 ml of sputum sample, either from normal or COPD patients, was added to an equal volume of conc. HCl and hydrolyzed at 110°C for 24 h. The acid hydrolyzed mixture was chromatographed on the cation-exchange column as described in the analysis of the urine samples. The content of D and I was analyzed by LC͞ESIMS. (Fig. 1a) Fig. 1 b and c) . Although the fragmentation ions with both isomers are similar, differences in their intensity can be used to differentiate the two isomers; the more intense ion fragments of m͞z 396 and 351 in I (the elimination of the amino acid substituent at the pyridinium nitrogen) can serve this purpose. The most abundant [M] ϩ at m͞z 526 was chosen for the SIR mode for quantitative analysis of D and I. 
Quantitative Analysis of Free and Total D and I in Human Urine and
Sputum. Fig. 2 shows the SIR analysis of standards of both D and I from amounts of 0.10-50.00 ng. These plots were used as the calibration curves for quantifying D and I in urine and sputum samples. Fig. 3 shows typical SIR chromatograms obtained from the urine of a normal subject. Fig. 3a illustrates the chromatographic analysis (by LC͞ESIMS by using SIR of m͞z 526 atomic mass units) of the two reference compounds. Fig. 3b shows the analysis of the total D and I content of normal urine after acid hydrolysis. Fig. 3c shows the analysis of the free D and I content of the same normal unhydrolyzed urine.
The commonly used HPLC methods for the analysis of D and I in urines all use their UV absorption at 268 nm for detection, which has a detection sensitivity of Ϸ1͞100th that of the SIR method used here. The SIR method permits the analysis of 0.1 ng (0.2 pmol) of D or I. The sensitivity and specificity of the SIR analysis make unnecessary the acid hydrolysis of 20-30 ml of urine, and the subsequent time-consuming cleanup procedures, which are needed to remove the impurities interfering with the UV absorption. In fact, the D and I in the urine samples analyzed by the SIR method, shown in Fig. 3 b and c, could not be detected by their UV absorption due to the overwhelming intense background interferences (the chromatograms not shown). Tables 1 and 2 show the results obtained for the free and total D and I in the urine samples from seven normal human subjects. Each sample was analyzed three times, and the average values are expressed as microgram per gram of creatinine. The recoveries of D and I from urine samples were Ͼ90%, which had been established by the parallel analysis of reference standard solutions of D and I.
The average of free D and I in the unhydrolyzed urines of the seven healthy subjects were determined to be 1.42 Ϯ 1.16 and 1.39 Ϯ 1.04 g͞g creatinine, respectively (Table 1) ; these values are Ϸ15% of those of the total D and I. The values of free D and I in normal urine has not been reported previously.
The average of the total D and I in the urine of the seven healthy subjects was 8.67 Ϯ 3.75 and 6.28 Ϯ 2.87 g͞g creatinine, respectively ( Table 2) . These values approximate those reported by HPLC analysis; 7.5 Ϯ 1.7 and 6.8 Ϯ 1.4 g͞g creatinine (8) and by capillary zone electrophoresis, 9.31 Ϯ 2.75 and 7.34 Ϯ 1.95 g͞g creatinine (9) . On the other hand, values for total D and I excreted in the urine of healthy subjects determined by the RIAs (6, 16) were 5-10 times higher. Table 3 shows the values obtained by the LC͞ESIMS method for the total D and I content of sputum from patients diagnosed with COPD. Sputum samples obtained by sputum induction from three volunteers without lung disease revealed no detectable levels of free D and I. Further application of the method to the analysis of sputum samples and evaluation of their correlation to COPD will be described in subsequent reports. After completion of this paper, a report on LC͞ESIMS analysis of D and I appeared (23); however, the method was applied to the analysis of D and I in rat lung after the conc. HCl hydrolysis of whole lung tissue. 
